Decades of research have generated knowledge and tools that, in theory, could prevent all new HIV infections and ultimately eliminate AIDS. Reality falls far short, in part due to major pressing unmet needs, many of which fall within two domains: Continuum of Care (assuring that all HIV-infected individuals are diagnosed, connected to care, and maintained in care); and Personalized HIV Care (assuring optimally safe and effective therapy based on understanding determinants of inter-individual variability). The proposed Tennessee Center for AIDS Research (TN-CFAR) is located in the Southeastern US, the region with the greatest number of new HIV infections, and of persons living with HIV. Under the leadership of Prof. Simon Mallal (recruited to Vanderbilt to lead this Center) we have forged a unique partnership between a research- intensive institution (Vanderbilt University, VU), an academic health sciences center focused on minority and underserved populations (Meharry Medical College, MMC), and an academically engaged state health department (Tennessee Department of Health, TDH). Our vision is to have transformative, local and global translational impact. Guided by this vision, our mission is to coordinate institutional and community resources and focus efforts on high-priority targets to most effectively reduce the burden of HIV/AIDS and generalize these benefits nationally and globally. We will leverage complementary strengths of VU, MMC, and TDH to focus research efforts on unmet needs. This strategy we will also most effectively serve the traditional CFAR roles of institutional leadership, core service, and fosterig career development of junior investigators. We will focus on four specific aims: 1) To foster collaborations between VU, MMC, and TDH that focus resources and research to improve the continuum of care in Tennessee and beyond; 2) To coordinate research into determinants of interindividual variability in response to HIV interventions so as to improve personalized HIV care, outcomes, and resource utilization; 3) To create and act upon new opportunities for HIV clinical/translational research at MMC, and between MMC and VU; and 4) To develop and grow a new emphasis on HIV-focused community engaged research that will pervade this CFAR.

Public Health Relevance

Overall - NARRATIVE The Tennessee CFAR (TN-CFAR) is an HIV/AIDS research collaboration between Vanderbilt University, Meharry Medical College, and the Tennessee State Department of Health. The TN- CFAR aims to enhance HIV/AIDS-related research by coordinating institutional and community resources, with the goal of reducing the burden of HIV/AIDS in our state and generalizing these benefits nationally and internationally.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI110527-05
Application #
9671852
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Beaubien, Candice M
Project Start
2015-04-01
Project End
2020-03-31
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Stone Jr, Cosby A; Liu, Yiwei; Relling, Mary V et al. (2018) Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized. J Allergy Clin Immunol Pract :
Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459
Leger, Paul; Chirwa, Sanika; Nwogu, Jacinta N et al. (2018) Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation. Pharmacogenet Genomics 28:1-6
Trubiano, Jason A; Strautins, Kaija; Redwood, Alec J et al. (2018) The Combined Utility of Ex Vivo IFN-? Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions. J Allergy Clin Immunol Pract 6:1287-1296.e1
McGoy, Shanell L; Pettit, April C; Morrison, Melissa et al. (2018) Use of Social Network Strategy Among Young Black Men Who Have Sex With Men for HIV Testing, Linkage to Care, and Reengagement in Care, Tennessee, 2013-2016. Public Health Rep 133:43S-51S
Tan, Yi; Pickett, Brett E; Shrivastava, Susmita et al. (2018) Differing epidemiological dynamics of Chikungunya virus in the Americas during the 2014-2015 epidemic. PLoS Negl Trop Dis 12:e0006670
Trubiano, Jason A; Douglas, Abby P; Goh, Michelle et al. (2018) The safety of antibiotic skin testing in severe T-cell-mediated hypersensitivity of immunocompetent and immunocompromised hosts. J Allergy Clin Immunol Pract :
Stone Jr, Cosby A; Hemler, Jonathan A; Commins, Scott P et al. (2018) Reply. J Allergy Clin Immunol 141:1957-1958
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Cook, Kathryn M; Gillon, Jessica; Grisso, Alison G et al. (2018) Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin-Tazobactam or Cefepime: A Cohort Study. J Pediatric Infect Dis Soc :

Showing the most recent 10 out of 126 publications